K. Mirzaev

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
K B Mirzaev, Karin Badavievich Mirzaev, Karin B. Mirzaev, Karin B Mirzaev, Karin Mirzaev, K. B. Mirzaev
Publication record
37 papers · 229 citations · H-index 8

PAPERS

Sertraline safety in adolescents experiencing a depressive episode during first 3 weeks: added anxiolytic matters more than CYP2C19 polymorphisms
20260 citationsauthor #11
Impact of Xenobiotic Detoxification Gene Polymorphisms on Steady-State Plasma Concentrations of Apixaban and the Development of Hemorrhagic Complications in Older Patients with Non-Valvular Atrial Fibrillation
20251 citationsauthor #6
Polymorphisms of the HTR2C Gene as Predictors of Metabolic Disturbances During Clozapine Therapy: A Systematic Review and Meta-Analysis
20253 citationsauthor #4
Antiplatelet therapy in the treatment of acute coronary syndrome in elderly patients
20251 citationsauthor #3
Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management
20250 citationsauthor #7
An Investigational Study on the Role of ADME Agents’ Genetic Variation on DD217 Pharmacokinetics and Safety Profile
20250 citationsauthor #8
The role of CYP2C19 gene variants in the development of bleeding in patients receiving clopidogrel as part of dual antithrombotic therapy: a clinical case of a patient with coronary heart disease and atrial fibrillation after acute coronary syndrome
20240 citationsauthor #3
CRT-100.25 MicroRNAs as Novel Biomarkers to Guide DAPT After PCI – Preliminary Assessment
20230 citationsauthor #2
Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy
20239 citationsauthor #4
MicroRNAs as Novel Biomarkers to Guide DAPT After PCI – Preliminary Assessment
20230 citationsauthor #2
Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
20230 citationsauthor #6
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation
20223 citationsauthor #4
Effect of polymorphisms in CYP3A4*22 (rs35599367) C>T, CYP3A5*3 (rs776746) A>G, ABCB1 (rs4148738) C>T and ABCB1 (rs1045642) C>T genes on apixaban anticoagulation: pilot study results
20210 citationsauthor #25
PGPM_A_324612 1575..1582
20210 citationsauthor #2
The CES1 Gene rs2244613 Minor Allele Impact on the Safety Profile of Dabigatran Etexilate: Meta-Analysis
20202 citationsauthor #2
Interethnic differences in the prevalence of main cardiovascular pharmacogenetic biomarkers.
20209 citationsauthor #1
Clinically relevant pharmacogenetic markers in Tatars and Balkars
20206 citationsauthor #2
New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants
20206 citationsauthor #1
Genotyping and phenotyping CYP3A4\CYP3A5: no association with antiplatelet effect of clopidogrel
20193 citationsauthor #1
[Micro-RNA as a new biomarker of activity of the cytochrome system P-450: significance for predicting the antiplatelet action of P2Y12 receptor inhibitors].
20198 citationsauthor #3
Approaches to predicting the efficacy and safety of amlodipine in patients with arterial hypertension of I–II degree based on pharmacogenetic studies
20190 citationsauthor #5
Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis
20199 citationsauthor #3
Effects of the rs2244613 polymorphism of the CES1 gene on the antiplatelet effect of the receptor P2Y12 blocker clopidogrel
201910 citationsauthor #1
The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty [Corrigendum]
20180 citationsauthor #7
Pharmacogenetic testing by polymorphic markers 681G>A and 636G>A CYP2C19 gene in patients with acute coronary syndrome and gastric ulcer in the Republic of Sakha (Yakutia)
20187 citationsauthor #2
The impact of ABCB1 (rs1045642 and rs4148738) and CES1 (rs2244613) gene polymorphisms on dabigatran equilibrium peak concentration in patients after total knee arthroplasty
201857 citationsauthor #7
Pharmacogenetic testing by polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease patients taking ββ-blockers in the Republic of Sakha (YAKUTIA)
20187 citationsauthor #2
The ABCB1, CYP2C19, CYP3A5 and CYP4F2 genetic polymorphisms and platelet reactivity in the early phases of acute coronary syndromes
20188 citationsauthor #1
NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME
20180 citationsauthor #1
CRT-100.09 The Impact of CYP2C19, ABCB1 Genes Polymorphisms and CYP3A4 Isoenzyme Activity on the Incidence of Stent Implantation Complications for Patients With an Acute Coronary Syndrome
20171 citationsauthor #1
Genetic Polymorphisms of Cytochrome P450 Enzymes and Transport Proteins in a Russian Population and Three Ethnic Groups of Dagestan
201716 citationsauthor #1
Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?
20177 citationsauthor #2
Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration
201718 citationsauthor #8
Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations
201715 citationsauthor #5
Association between polymorphism gene ABCB1, encodes glycoprotein P, and efficacy and safety profile of haloperidol in patients with alcohol addiction
20172 citationsauthor #3
INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
20150 citationsauthor #1
Cytochrome 2C19 Enzyme Polymorphism Frequency in Different Indigenous Ethnic Groups in Russian Federation: A Systematic Review
20132 citationsauthor #1
Pharmacogenomics and Personalized Medicine Dovepress Cyp2c19 Polymorphism Frequency in Russian Patients in Central Russia and Siberia with Acute Coronary Syndrome Konstantin a Apartsin 4,5
year unknown21 citationsauthor #1

TIMELINE

2013 2 citations

2015 0 citations

2017 59 citations

2018 79 citations

2019 30 citations

2020 23 citations

2021 0 citations

2022 3 citations

2023 9 citations

2024 0 citations

2025 5 citations

2026 0 citations

Unknown 21 citations

K. Mirzaev

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT